79335-75-4

Basic information

• Product Name: FK 565
• Synonyms: N-[(6R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-γ-glutamyl]-L-lysyl]-D-alanine;FK 565;FR-41565;FR-53476;Heptanoyl-α-D-glutamyl-(L)-meso-diaminopimelyl-(D)-alanine;N-(1-oxoheptyl)-D-γ-glutamyl-L-erythro-α,ε-diaminopimelyl-D-alanine
• CAS NO: 79335-75-4
• Molecular Formula: C22H38N4O9
• Molecular Weight: 502.55852
• Mol File: 79335-75-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 924.1°C at 760 mmHg
• Flash Point: 512.7°C
• Appearance: /
• Density: 1.26g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.528
• CAS DataBase Reference: FK 565(CAS DataBase Reference)
• NIST Chemistry Reference: FK 565(79335-75-4)
• EPA Substance Registry System: FK 565(79335-75-4)

Safety Data

• Hazardous Substances Data: 79335-75-4(Hazardous Substances Data)

Usage

Description

FK 565, also known as N-[(R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-γ-glutamyl]-L-lysyl]-D-alanine, is an immunoactive peptide derived from fetal vascular tissues. It has the ability to upregulate various genes associated with immune responses, such as apoptosis and inflammation, making it a promising candidate for therapeutic applications.

Uses

Used in Pharmaceutical Industry:
FK 565 is used as an immunoactive peptide for its ability to upregulate genes associated with immune responses in fetal vascular tissues. This property makes it a potential therapeutic agent for various conditions, including experimental and spontaneous metastases.
Used in Immunotherapy:
FK 565 is used as an immunotherapeutic agent for its potential to modulate immune responses and exhibit therapeutic properties in treating metastases. Its ability to upregulate genes associated with immune responses makes it a valuable tool in the development of novel treatments for various diseases.
Used in Research and Development:
FK 565 is used as a research tool for studying the mechanisms of immune responses and gene regulation in fetal vascular tissues. Its unique properties make it a valuable asset in the development of new therapeutic strategies and understanding the underlying biology of various diseases.

InChI:InChI=1/C22H38N4O9/c1-3-4-5-6-10-17(27)26-16(22(34)35)11-12-18(28)25-15(9-7-8-14(23)21(32)33)19(29)24-13(2)20(30)31/h13-16H,3-12,23H2,1-2H3,(H,24,29)(H,25,28)(H,26,27)(H,30,31)(H,32,33)(H,34,35)/t13-,14-,15+,16-/m1/s1